Articles from Neupril

Casper, WY, Nov. 04, 2025 (GLOBE NEWSWIRE) -- With research showing that up to 60% of individuals carry MTHFR gene variants that may reduce the body’s ability to convert folic acid into active folate, Neupril introduces a clinically active L-Methylfolate formula designed to help address this nutritional challenge. The formulation provides a bioavailable form of folate that the body can utilize directly, supporting pathways related to mood, energy, and cognitive health. Neupril’s approach combines evidence-based formulation practices with a focus on integrity, transparency, and public education in the supplement industry.